Cytokines, sickness behavior, and depression

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 281-318

  Dantzer, Robert ^a   Bluthé, Rose Marie ^b   Castanon, Nathalie ^b   Kelley, Keith W ^a   Konsman, Jan Pieter ^b   Laye, Sophie ^b   Lestage, Jacques ^b   Parnet, Patricia ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882478683     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50019-8     Document Type: Chapter

References (307)

1. Alberati-Giani D., Ricciardi-Castagnoli P., Kohler C., Cesura A.M. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J. Neurochem. 1996, 66:996-1004.
2. Alleva E., Cirulli F., Bianchi M., Bondiolotti G.P., Chiarotti F., De Acetis L., Panerai A.E. Behavioural characterization of interleukin-6 overexpressing or deficient mice during agonistic encounters. Eur. J. Neurosci. 1998, 10:3664-3672.
3. Anisman H., Hayley S., Turrin N., Merali Z. Cytokines as a stressor: implications for depressive illness. Int. J. Neuropsychopharmacol. 2002, 5:357-373.
4. Anisman H., Kokkinidis L., Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 2002, 16:544-556.
5. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 1999, 461:199-233.
6. Anisman H., Turrin N.P., Merali Z., Hayley S. Neurochemical sensitization associated with systemic administration of tumor necrosis factor-alpha: adjuvant action in combination with bovine serum albumin. J. Neuroimmunol. 2003, 145:91-102.
7. Armario A., Hernandez J., Bluethmann H., Hidalgo J. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J. Neuroimmunol. 1998, 92:160-169.
8. Aubert A., Dantzer R. The taste of sickness: lipopolysaccharide-induced finickiness in rats. Physiol. Behav. 2005, 84:437-444.
9. Aubert A., Goodall G., Dantzer R. Compared effects of cold ambient temperature and cytokines on macronutrient intake in rats. Physiol. Behav. 1995, 57:869-873.
10. Aubert A., Goodall G., Dantzer R., Gheusi G. Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav. Immun. 1997, 11:107-118.
11. Aubert A., Kelley K.W., Dantzer R. Differential effect of lipopolysaccharide on food hoarding behavior and food consumption in rats. Brain Behav. Immun. 1997, 11:229-238.
12. Avitsur R., Cohen E., Yirmiya R. Effects of interleukin-1 on sexual attractivity in a model of sickness behavior. Physiol. Behav. 1997, 63:25-30.
13. Avitsur R., Pollak Y., Yirmiya R. Administration of interleukin-1 into the hypothalamic paraventricular nucleus induces febrile and behavioral effects. Neuroimmunomodulation. 1997, 4:258-265.
14. Avitsur R., Pollak Y., Yirmiya R. Different receptor mechanisms mediate the effects of endotoxin and interleukin-1 on female sexual behavior. Brain Res. 1997, 773:149-161.
15. Avitsur R., Yirmiya R. The immunobiology of sexual behavior: gender differences in the suppression of sexual activity during illness. Pharmacol. Biochem. Behav. 1999, 64:787-796.
16. Ban E., Marquette C., Sarrieau A., Fitzpatrick F., Fillion G., Milon G., et al. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology. 1993, 58:581-587.
17. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience. 1991, 43:21-30.
18. Bandler R., Keay K.A., Floyd N., Price J. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res. Bull. 2000, 53:95-104.
19. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 2005, 11:973-984.
20. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 2001, 299:536-541.
21. Barak O., Goshen I., Ben-Hur T., Weidenfeld J., Taylor A.N., Yirmiya R. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 2002, 933:98-108.
22. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science. 2003, 300:1524-1525.
23. Baura G.D., Foster D.M., Porte D., Kahn S.E., Bergman R.N., Cobelli C., Schwartz M.W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 1993, 92:1824-1830.
24. Bellezzo J.M., Leingang K.A., Bulla G.A., Britton R.S., Bacon B.R., Fox E.S. Modulation of lipopolysaccharidemediated activation in rat Kupffer cells by antioxidants. J. Lab. Clin. Med. 1998, 131:36-44.
25. Ben-Hur T., Cialic R., Itzik A., Barak O., Yirmiya R., Weidenfeld J. A novel permissive role for glucocorticoids in induction of febrile and behavioral signs of experimental herpes simplex virus encephalitis. Neuroscience. 2001, 108:119-127.
26. Berg B.M., Godbout J.P., Kelley K.W., Johnson R.W. Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav. Immun. 2004, 18:149-157.
27. Bertini R., Bianchi M., Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 1988, 167:1708-1712.
28. Besedovsky H., del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986, 233:652-654.
29. Besedovsky H.O., del Rey A. The cytokine-HPA axis feed-back circuit. Z. Rheumatol. 2000, 59(Suppl 2):26-30. II.
30. Betancur C., Lledo A., Borrell J., Guaza C. Corticosteroid regulation of IL-1 receptors in the mouse hippocampus: effects of glucocorticoid treatment, stress, and adrenalectomy. Neuroendocrinology. 1994, 59:120-128.
31. Bianco F., Pravettoni E., Colombo A., Schenk U., Moller T., Matteoli M., Verderio C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 2005, 174:7268-7277.
32. Bilbo S.D., Drazen D.L., Quan N., He L., Nelson R.J. Short day lengths attenuate the symptoms of infection in Siberian hamsters. Proc. Biol. Sci. 2002, 269:447-454.
33. Blatteis C.M. Neuromodulative actions of cytokines. Yale J. Biol. Med. 1990, 63:133-146.
34. Blount J.D., Metcalfe N.B., Birkhead T.R., Surai P.F. Carotenoid modulation of immune function and sexual attractiveness in zebra finches. Science. 2003, 300:125-127.
35. Bluthe R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology. 1999, 24:301-311.
36. Bluthe R.M., Crestani F., Kelley K.W., Dantzer R. Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Ann. N. Y. Acad. Sci. 1992, 650:268-275.
37. Bluthe R.M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 1992, 573:318-320.
38. Bluthe R.M., Frenois F., Kelley K.W., Dantzer R. Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice. J. Neuroimmunol. 2005, 169:50-58.
39. Bluthe R.M., Jafarian-Tehrani M., Michaud B., Haour F., Dantzer R., Homo-Delarche F. Increased sensitivity of pre-diabetic nonobese diabetic mouse to the behavioral effects of IL-1. Brain Behav. Immun. 1999, 13:303-314.
40. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-defic. Eur. J. Neurosci. 2000, 12:4447-4456.
41. Bluthe R.M., Michaud B., Delhaye-Bouchaud N., Mariani J., Dantzer R. Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour. Neuroreport. 1997, 8:1119-1122.
42. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport. 1996, 7:1485-1488.
43. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport. 1996, 7:2823-2827.
44. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Physiol. Behav. 1997, 62:385-389.
45. Bluthe R.M., Michaud B., Poli V., Dantzer R. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 2000, 70:367-373.
46. Bluthe R.M., Pawlowski M., Suarez S., Parnet P., Pittman Q., Kelley K.W., Dantzer R. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology. 1994, 19:197-207.
47. Bluthe R.M., Sparber S., Dantzer R. Modulation of the behavioural effects of interleukin-1 in mice by nitric oxide. Neuroreport. 1992, 3:207-209.
48. Bluthe R.M., Walter V., Parnet P., Laye S., Lestage J., Verrier D., et al. Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C. R. Acad. Sci. III. 1994, 317:499-503.
49. Bolles R.C. Species-specific defense reactions and avoidance learning. Psychol. Rev. 1970, 77:32-48.
50. Bonaccorso S., Maier S.F., Meltzer H.Y., Maes M. Behavioral changes in rats after acute, chronic and repeated administration of interleukin-1beta: relevance for affective disorders. J. Affect. Disord. 2003, 77:143-148.
51. Borsody M.K., Weiss J.M. The subdiaphragmatic vagus nerves mediate activation of locus coeruleus neurons by peripherally administered microbial substances. Neuroscience. 2005, 131:235-245.
52. Breder C.D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. USA. 1994, 91:11393-11397.
53. Breder C.D., Saper C.B. Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res. 1996, 713:64-69.
54. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., Dantzer R. Lipopolysaccharide and interleukin-1 depress foodmotivated behavior in mice by a vagal-mediated mechanism. Brain Behav. Immun. 1995, 9:242-246.
55. Buller K.M., Day T.A. Systemic administration of interleukin-1beta activates select populations of central amygdala afferents. J. Comp. Neurol. 2002, 452:288-296.
56. Burgess W., Gheusi G., Yao J., Johnson R.W., Dantzer R., Kelley K.W. Interleukin-1beta-converting enzymedeficient mice resist central but not systemic endotoxin-induced anorexia. Am. J. Physiol. 1998, 274:R1829-R1833.
57. Burudi E.M., Marcondes M.C., Watry D.D., Zandonatti M., Taffe M.A., Fox H.S. Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virusinfected monkey brains. J. Virol. 2002, 76:12233-12241.
58. Buttini M., Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells. Neuroscience. 1995, 65:523-530.
59. Calapai G., Mazzaglia G., Cilia M., Zingarelli B., Squadrito F., Caputi A.P. Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat. Br. J. Pharmacol. 1994, 111:1328-1332.
60. Campbell I.L., Stalder A.K., Akwa Y., Pagenstecher A., Asensio V.C. Transgenic models to study the actions of cytokines in the central nervous system. Neuroimmunomodulation. 1998, 5:126-135.
61. Cao C., Matsumura K., Yamagata K., Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synt responsible for fever. Brain Res. 1996, 733:263-272.
62. Capuron L., Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 2003, 17(Suppl 1):S119-S124.
63. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol. Psychiatry. 2004, 56:819-824.
64. Capuron L., Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. N. Engl. J. Med. 1999, 340:1370.
65. Capuron L., Ravaud A., Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J. Clin. Oncol. 2000, 18:2143-2151.
66. Capuron L., Ravaud A., Dantzer R. Timing and speci-ficity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom. Med. 2001, 63:376-386.
67. Capuron L., Ravaud A., Gualde N., Bosmans E., Dantzer R., Maes M., Neveu P.J. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology. 2001, 26:797-808.
68. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry. 2002, 7:468-473.
69. Chauvet N., Palin K., Verrier D., Poole S., Dantzer R., Lestage J. Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide. Eur. J. Neurosci. 2001, 14:609-617.
70. Cirulli F., De Acetis L., Alleva E. Behavioral effects of peripheral interleukin-1 administration in adult CD-1 mice: specific inhibition of the offensive components of intermale agonistic beha. Brain Res. 1998, 791:308-312.
71. Coelho M.M., Souza G.E., Pela I.R. Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am. J. Physiol. 1992, 263. R423-427.
72. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in preclinical murine prion disease. Neuroscience. 2002, 112:7-11.
73. Connor T.J., Harkin A., Kelly J.P., Leonard B.E. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopoly effect of chronic desipramine treatment. Neuroimmunomodulation 2000, 7:27-35.
74. Connor T.J., O'Sullivan J., Nolan Y., Kelly J.P. Inhibition of constitutive nitric oxide production increases the severity of lipopolysaccharide-induced sickness behaviour: a role for TNF-alpha. Neuroimmunomodulation. 2002, 10:367-378.
75. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta,-2,-6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine parameters in the rat. Neuroscience. 1998, 84:923-933.
76. Cremona S., Goujon E., Kelley K.W., Dantzer R., Parnet P. Brain type I but not type II IL-1 receptors mediate the effects of IL-1 beta on behavior in mice. Am. J. Physiol. 1998, 274:R735-R740.
77. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1, role of prostaglandins. Brain Res. 1991, 542:330-335.
78. Cross-Mellor S.K., Kavaliers M., Ossenkopp K.P. Comparing immune activation (lipopolysaccharide) and toxin (lithium chloride) -induced gustatory conditioning: lipopolysaccharide produces conditioned taste a but not aversion. Behav. Brain Res. 2004, 148:11-19.
79. Cross-Mellor S.K., Kent W.D., Ossenkopp K.P., Kavaliers M. Differential effects of lipopolysaccharide and cholecystokinin on sucrose intake and palatability. Am. J. Physiol. 1999, 277. R705-715.
80. Cross-Mellor S.K., Roberts S., Kavaliers M., Ossenkopp K.P. Activation of the immune system in rats with lipopolysaccharide reduces voluntary sucrose intake but not intraoral intake. Pharmacol. Biochem. Behav. 2003, 76:153-159.
81. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
82. Dantzer R. Innate immunity at the forefront of psychoneuroimmunology. Brain Behav. Immun. 2004, 18:1-6.
83. Dantzer R., Bluthe R.M. Vasopressin involvement in antipyresis, social communication, and social recognition: a synthesis. Crit. Rev. Neurobiol. 1992, 6:243-255.
84. Dantzer R., Bluthe R.M., Kelley K.W. Androgendependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior. Brain Res. 1991, 557:115-120.
85. Dantzer R., Gheusi G., Johnson R.W., Kelley K.W. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. Neuroreport. 1999, 10:289-292.
86. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci. 1989, 44:1995-2008.
87. Dantzer R., Konsman J.P., Bluthe R.M., Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?. Auton. Neurosci. 2000, 85:60-65.
88. Daun J.M., McCarthy D.O. The role of cholecystokinin in interleukin-1-induced anorexia. Physiol. Behav. 1993, 54:237-241.
89. De La Garza R., Fabrizio K.R., Radoi G.E., Vlad T., Asnis G.M. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav. Brain Res. 2004, 149:77-85.
90. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 1998, 16:457-499.
91. Dunn A.J., Swiergiel A.H. The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment. Neuroimmunomodulation. 2001, 9:163-169.
92. Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 1999, 461:117-127.
93. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
94. Elmquist J.K., Breder C.D., Sherin J.E., Scammell T.E., Hickey W.F., Dewitt D., Saper C.B. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J. Comp. Neurol. 1997, 381:119-129.
95. Elmquist J.K., Scammell T.E., Jacobson C.D., Saper C.B. Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J. Comp. Neurol. 1996, 371:85-103.
96. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 1994, 14:897-913.
97. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 1995, 361:681-698.
98. Evans D.L., Charney D.S., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., et al. Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychiatry. 2005, 58:175-189.
99. Faggioni R., Fantuzzi G., Fuller J., Dinarello C.A., Feingold K.R., Grunfeld C. IL-1 beta mediates leptin induction during inflammation. Am. J. Physiol. 1998, 274:R204-R208.
100. Faggioni R., Fuller J., Moser A., Feingold K.R., Grunfeld C. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice. Am. J. Physiol. 1997, 273:R181-R186.
101. Faivre B., Gregoire A., Preault M., Cezilly F., Sorci G. Immune activation rapidly mirrored in a secondary sexual trait. Science. 2003, 300:103.
102. Fernstrom J.D., Wurtman R.J. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science. 1971, 173:149-152.
103. Ferrari D., Chiozzi P., Falzoni S., Hanau S., Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 1997, 185:579-582.
104. Ferri C.C., Ferguson A.V. Prostaglandin E2 mediates cellular effects of interleukin-1beta on parvocellular neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 2005, 17:498-508.
105. Ferri C.C., Yuill E.A., Ferguson A.V. Interleukin-1beta depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non sele cationic conductance. Regul. Pept. 2005, 129:63-71.
106. Finck B.N., Kelley K.W., Dantzer R., Johnson R.W. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology 1998, 139:2278-2283.
107. Fiore M., Alleva E., Probert L., Kollias G., Angelucci F., Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol. Behav. 1998, 63:571-576.
108. Francis J., MohanKumar P.S., MohanKumar S.M., Quadri S.K. Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor. Endocrine. 1999, 10:291-295.
109. Gabellec M.M., Jafarian-Tehrani M., Griffais R., Haour F. Interleukin-1 receptor accessory protein transcripts in the brain and spleen: kinetics after peripheral administration of bacterial lipopolysaccharide in mice. Neuroimmunomodulation. 1996, 3:304-309.
110. Gatti S., Bartfai T. Induction of tumor necrosis factoralpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res.. 1993, 624:291-294.
111. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroin-flammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
112. Goehler L.E., Busch C.R., Tartaglia N., Relton J., Sisk D., Maier S.F., Watkins L.R. Blockade of cytokine induced conditioned taste aversion by subdiaphragmatic vagotomy: further evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 1995, 185:163-166.
113. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
114. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., Watkins L.R. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 1999, 19:2799-2806.
115. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 1997, 43:357-364.
116. Goujon E., Parnet P., Aubert A., Goodall G., Dantzer R. Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1 beta in mice. Am. J. Physiol. 1995, 269:R154-R159.
117. Goujon E., Parnet P., Cremona S., Dantzer R. Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice. Brain Res. 1995, 702:173-180.
118. Goujon E., Parnet P., Laye S., Combe C., Dantzer R. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res. Mol. Brain Res. 1996, 36:53-62.
119. Goujon E., Parnet P., Laye S., Combe C., Kelley K.W., Dantzer R. Stress downregulates lipopolysaccharideinduced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice. Brain Behav. Immun. 1995, 9:292-303.
120. Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 1995, 270:13757-13765.
121. Grippo A.J., Francis J., Weiss R.M., Felder R.B., Johnson A.K. Cytokine mediation of experimental heart failureinduced anhedonia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R666-R673.
122. Grunfeld C., Feingold K.R. Regulation of lipid metabolism by cytokines during host defense. Nutrition. 1996, 12:S24-S26.
123. Guillemin G.J., Smythe G., Takikawa O., Brew B.J. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005, 49:15-23.
124. Haddad J.J., Safieh-Garabedian B., Saade N.E., Lauterbach R. Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IkappaB/ NF-kappaB-sensitive pathway in the alveolar. Int. Immunopharmacol. 2002, 2:1567-1583.
125. Hansen M.K., Daniels S., Goehler L.E., Gaykema R.P., Maier S.F., Watkins L.R. Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton. Neurosci. 2000, 85:83-87.
126. Hansen M.K., Nguyen K.T., Fleshner M., Goehler L.E., Gaykema R.P., Maier S.F., Watkins L.R. Effects of vagotomy on serum endotoxin, cytokines, and corticosterone after intraperitoneal lipopolysaccharide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R331-R336.
127. Hansen M.K., Nguyen K.T., Goehler L.E., Gaykema R.P., Fleshner M., Maier S.F., Watkins L.R. Effects of vagotomy on lipopolysaccharide-induced brain interleukin-1beta protein in rats. Auton. Neurosci. 2000, 85:119-126.
128. Hansen M.K., Taishi P., Chen Z., Krueger J.M. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J. Neurosci. 1998, 18:2247-2253.
129. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
130. Hassanain M., Bhatt S., Zalcman S., Siegel A. Potentiating role of interleukin-1beta (IL-1beta) and IL-1beta type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat. Brain Res. 2005, 1048:1-11.
131. Hayley S., Kelly O., Anisman H. Murine tumor necrosis factor-alpha sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine. J. Neuroimmunol. 2002, 131:60-69.
132. Hayley S., Wall P., Anisman H. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms. Eur. J. Neurosci. 2002, 15:1061-1076.
133. Hellerstein M.K., Meydani S.N., Meydani M., Wu K., Dinarello C.A. Interleukin-1-induced anorexia in the rat. influence of prostaglandins. J. Clin. Invest. 1989, 84:228-235.
134. Herkenham M., Lee H.Y., Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1, a cascade of non-neuronal cellular activation at the bloodbrain barrier. J. Comp. Neurol. 1998, 400:175-196.
135. Hetier E., Ayala J., Bousseau A., Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp. Brain Res. 1991, 86:407-413.
136. Hirschfeld R.M. Antidepressants in long-term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr. Scand SUPPL. 2000, 403:35-38.
137. Hirschfeld R.M. History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry. 2000, 61(Suppl 6):4-6.
138. Hosoi T., Okuma Y., Wada S., Nomura Y. Inhibition of leptin-induced IL-1beta expression by glucocorticoids in the brain. Brain Res. 2003, 969:95-101.
139. Jhou T. Neural mechanisms of freezing and passive aversive behaviors. J. Comp. Neurol. 2005, 493:111-114.
140. Johnson P.M., Vogt S.K., Burney M.W., Muglia L.J. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E650-E656.
141. Kakucska I., Qi Y., Clark B.D., Lechan R.M. Endotoxin-induced corticotropin-releasing hormone gene ex-pression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology. 1993, 133:815-821.
142. Kanaan S.A., Poole S., Saade N.E., Jabbur S., Safieh-Garabedian B. Interleukin-10 reduces the endotoxininduced hyperalgesia in mice. J. Neuroimmunol. 1998, 86:142-150.
143. Kaneta T., Kusnecov A.W. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A. Brain Behav. Immun. 2005, 19:138-146.
144. Kavanagh T., Lonergan P.E., Lynch M.A. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of lon potentiation. Prostaglandins Leukot. Essent. Fatty Acids. 2004, 70:391-397.
145. Kawashima N., Kusnecov A.W. Effects of staphylococcal enterotoxin A on pituitary-adrenal activation and neophobic behavior in the C57BL/6 mouse. J. Neuroimmunol. 2002, 123:41-49.
146. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Natl. Acad. Sci. USA. 1992, 89:9117-9120.
147. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24-28.
148. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 1996, 20:171-175.
149. Kent S., Kelley K.W., Dantzer R. Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci. Lett. 1992, 145:83-86.
150. Kent S., Rodriguez F., Kelley K.W., Dantzer R. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiol. Behav. 1994, 56:1031-1036.
151. Kheir-Eldin A.A., Motawi T.K., Gad M.Z., Abd-ElGawad H.M. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int. J. Biochem. Cell Biol. 2001, 33:475-482.
152. Klir J.J., McClellan J.L., Kluger M.J. Interleukin-1 beta causes the increase in anterior hypothalamic interleukin-6 during LPS-induced fever in rats. Am. J. Physiol. 1994, 266:R1845-R1848.
153. Kluger M.J. Fever: role of pyrogens and cryogens. Physiol. Rev. 1991, 71:93-127.
154. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience. 1999, 89:535-548.
155. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 2000, 12:4434-4446.
156. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002, 25:154-159.
157. Konsman J.P., Tridon V., Dantzer R. Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience. 2000, 101:957-967.
158. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripher ammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
159. Kozak W., Poli V., Soszynski D., Conn C.A., Leon L.R., Kluger M.J. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 1997, 272:R621-R630.
160. Kozak W., Soszynski D., Rudolph K., Conn C.A., Kluger M.J. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. Am. J. Physiol. 1997, 272:R1298-R1307.
161. Kubera M., Basta-Kaim A., Holan V., Simbirtsev A., Roman A., Pigareva N., et al. Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. Int. J. Immunopharmacol. 1998, 20:781-789.
162. Kubera M., Maes M., Holan V., Basta-Kaim A., Roman A., Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stre of depression. J. Affect Disord. 2001, 63:171-178.
163. Kurumaji A., Umino A., Tanami M., Ito A., Asakawa M., Nishikawa T. Distribution of anxiogenic-induced c-Fos in the forebrain regions of developing rats. J. Neural Transm. 2003, 110:1161-1168.
164. Kusnecov A.W., Goldfarb Y. Neural and behavioral responses to systemic immunologic stimuli: a consideration of bacterial T cell superantigens. Curr. Pharm. Des. 2005, 11:1039-1046.
165. Kusnecov A.W., Liang R., Shurin G. T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty. J. Neurosci. 1999, 19:4533-4543.
166. Kwidzinski E., Bunse J., Aktas O., Richter D., Mutlu L., Zipp F., et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J. 2005, 19:1347-1349.
167. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat b. J. Neurochem. 1998, 70:452-466.
168. Langhans W., Harlacher R., Balkowski G., Scharrer E. Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake. Physiol. Behav. 1990, 47:805-813.
169. Langhans W., Harlacher R., Scharrer E. Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiol. Behav. 1989, 46:535-539.
170. Larson S.J., Romanoff R.L., Dunn A.J., Glowa J.R. Effects of interleukin-1beta on food-maintained behavior in the mouse. Brain Behav. Immun. 2002, 16:398-410.
171. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., et al. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 1995, 268:R1327-R1331.
172. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., Parnet P. Endogenous brain IL-1 mediates LPSinduced anorexia and hypothalamic cytokine expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R93-R98.
173. Laye S., Goujon E., Combe C., VanHoy R., Kelley K.W., Parnet P., Dantzer R. Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1 beta converting enzyme in the pituitary and brain of mice. J. Neuroimmunol. 1996, 68:61-66.
174. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 1994, 27:157-162.
175. Lee S.W., Tsou A.P., Chan H., Thomas J., Petrie K., Eugui E.M., Allison A.C. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc. Natl. Acad. Sci. USA. 1988, 85:1204-1208.
176. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol. Behav. 1990, 47:957-961.
177. Lenczowski M.J., Bluthe R.M., Roth J., Rees G.S., Rushforth D.A., van Dam A.M., et al. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am. J. Physiol. 1999, 276:R652-R658.
178. Leon L.R., Kozak W., Rudolph K., Kluger M.J. An antipyretic role for interleukin-10 in LPS fever in mice. Am. J. Physiol. 1999, 276:R81-R89.
179. Lestage J., Verrier D., Palin K., Dantzer R. The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain. Behav. Immun. 2002, 16:596-601.
180. Linthorst A.C., Flachskamm C., Holsboer F., Reul J.M. Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature an hypothalamicpituitary-adrenocortical axis activity. Eur. J. Neurosci. 1995, 7:2418-2430.
181. Linthorst A.C., Flachskamm C., Holsboer F., Reul J.M. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of t cyclo-oxygenase pathway. Neuroscience. 1996, 72:989-997.
182. Linthorst A.C., Flachskamm C., Muller-Preuss P., Holsboer F., Reul J.M. Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in microdialysis study. J. Neurosci. 1995, 15:2920-2934.
183. Linthorst A.C., Reul J.M. Inflammation and brain function under basal conditions and during long-term elevation of brain corticotropin-releasing hormone levels. Adv. Exp. Med. Biol. 1999, 461:129-152.
184. Liu C., Chalmers D., Maki R., De Souza E.B. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J. Neuroimmunol. 1996, 66:41-48.
185. Luheshi G.N., Bluthe R.M., Rushforth D., Mulcahy N., Konsman J.P., Goldbach M., Dantzer R. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton. Neurosci. 2000, 85:127-132.
186. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. USA. 1999, 96:7047-7052.
187. Lyte M., Varcoe J.J., Bailey M.T. Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation. Physiol. Behav. 1998, 65:63-68.
188. Marquette C., van Dam A.M., Ban E., Laniece P., Crumeyrolle-Arias M., Fillion G., et al. Rat interleukin-1 beta binding sites in rat hypothalamus and pituitary gland. Neuroendocrinology. 1995, 62:362-369.
189. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav. Immun. 2004, 18:123-134.
190. McClellan J.L., Klir J.J., Morrow L.E., Kluger M.J. Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever. Am. J. Physiol. 1994, 267:R705-R711.
191. Merali Z., Brennan K., Brau P., Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for "free chow" and "earned" sucros. Psychopharmacology (Berl) 2003, 165:413-418.
192. Miczek K.A., Nikulina E., Kream R.M., Carter G., Espejo E.F. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology (Berl). 1999, 141:225-234.
193. Miller N.E. Some psychophysiological studies of motivation and of the behavioral effects of illness. Bulletin of the British Psychology Society. 1964, 17:1-20.
194. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci. Lett. 1991, 123:254-256.
195. MohanKumar S.M., MohanKumar P.S., Quadri S.K. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Res. 1999, 824:232-237.
196. Moore P., Landolt H.P., Seifritz E., Clark C., Bhatti T., Kelsoe J., et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology. 2000, 23:601-622.
197. Moreau M., Lestage J., Verrier D., Mormede C., Kelley K.W., Dantzer R., Castanon N. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J. Infect. Dis. 2005, 192:537-544.
198. Mormede C., Palin K., Kelley K.W., Castanon N., Dantzer R. Conditioned taste aversion with lipopolysaccharide and peptidoglycan does not activate cytokine gene expression in the spleen and hypothalamus of mice. Brain Behav. Immun. 2004, 18:186-200.
199. Morrow L.E., McClellan J.L., Conn C.A., Kluger M.J. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am. J. Physiol. 1993, 264:R1010-R1016..
200. Nadeau S., Rivest S. Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J. Neurosci. 2003, 23:5536-5544.
201. Nadjar A., Combe C., Laye S., Tridon V., Dantzer R., Amedee T., Parnet P. Nuclear factor kappaB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J. Neurochem. 2003, 87:1024-1036.
202. Nadjar A., Tridon V., May M.J., Ghosh S., Dantzer R., Amedee T., Parnet P. NFkappaB activates in vivo the synthesis of inducible COX-2 in the brain. J. Cereb. Blood Flow Metab. 2005, 25:1047-1059.
203. Nava F., Calapai G., Facciola G., Cuzzocrea S., Marciano M.C., De Sarro A., Caputi A.P. Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. Int. J. Immunopharmacol. 1997, 19:31-38.
204. Nelson R.J. Seasonal immune function and sickness responses. Trends Immunol. 2004, 25:187-192.
205. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry. 2005, 66(Suppl 7):5-13.
206. Nguyen K.T., Deak T., Will M.J., Hansen M.K., Hunsaker B.N., Fleshner M., et al. Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1beta protein response to acute stress. Brain Res. 2000, 859:193-201.
207. O'Connor J.C., Satpathy A., Hartman M.E., Horvath E.M., Kelley K.W., Dantzer R., et al. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J. Immunol. 2005, 174:4991-4997.
208. Onodera T., Watanabe R., Tha K.K., Hayashi Y., Murayama T., Okuma Y., et al. Depressive behavior and alterations in receptors for dopamine and 5-hydroxytryptamine in the brain of the senescence accelerated mouse. (SAM) -P10. Jpn. J. Pharmacol. 2000, 83:312-318.
209. Oprica M., Zhu S., Goiny M., Pham T.M., Mohammed A.H., Winblad B., et al. Transgenic overexpression of interleukin-1 receptor antagonist in the CNS influences behaviour, serum corticosterone and brain monoamines. Brain Behav. Immun. 2005, 19:223-234.
210. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 1994, 40:288-295.
211. Owens T., Renno T., Taupin V., Krakowski M. Inflammatory cytokines in the brain: does the CNS shape immune responses?. Immunol. Today. 1994, 15:566-571.
212. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J.A., et al. Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res. Mol. Brain Res. 1994, 27:63-70.
213. Pauli S., Linthorst A.C., Reul J.M. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat. Eur. J. Neurosci. 1998, 10:868-878.
214. Perry V.H. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 2004, 18:407-413.
215. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4:103-112.
216. Petitto J.M., McCarthy D.B., Rinker C.M., Huang Z., Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 1997, 73:183-190.
217. Phelps E.A., Ledoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron. 2005, 48:175-187.
218. Plata-Salaman C., Turrin N. Cytokine action in the brain. Mol. Psychiatry. 1999, 4:302.
219. Plata-Salaman C.R. Cytokines and feeding suppression: an integrative view from neurologic to molecular levels. Nutrition. 1995, 11:674-677.
220. Plata-Salaman C.R. Cytokines and anorexia: a brief overview. Semin. Oncol. 1998, 25:64-72.
221. Plata-Salaman C.R. 1998 Curt P. Richter Award. Brain mechanisms in cytokine-induced anorexia. Psychoneuroendocrinology. 1999, 24:25-41.
222. Plata-Salaman C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 1988, 448:106-114.
223. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., French-Mullen J.M.B. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol. Behav. 1996, 60:867-875.
224. Porter M.H., Hrupka B.J., Langhans W., Schwartz G.J. Vagal and splanchnic afferents are not necessary for the anorexia produced by peripheral IL-1beta, LPS, and MDP. Am. J. Physiol. 1998, 275:R384-R389.
225. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature. 1976, 260:731-732.
226. Pousset F., Cremona S., Dantzer R., Kelley K.W., Parnet P. Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes. J. Neurochem. 2001, 76:901-909.
227. Pyter L.M., Samuelsson A.R., Quan N., Nelson R.J. Photoperiod alters hypothalamic cytokine gene expression and sickness responses following immune challenge in female Siberian hamsters. (Phodopus sungorus). Neuroscience. 2005, 131:779-784.
228. Quan N., Avitsur R., Stark J.L., He L., Shah M., Caligiuri M., et al. Social stress increases the susceptibility to endotoxic shock. J. Neuroimmunol. 2001, 115:36-45.
229. Quan N., He L., Lai W. Endothelial activation is an intermediate step for peripheral lipopolysaccharide induced activation of paraventricular nucleus. Brain Res. Bull. 2003, 59:447-452.
230. Quan N., Whiteside M., Kim L., Herkenham M. Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization his study in the rat. Proc. Natl. Acad. Sci. USA. 1997, 94:10985-10990.
231. Rady P.L., Smith E.M., Cadet P., Opp M.R., Tyring S.K., Hughes T.K. Presence of interleukin-10 transcripts in human pituitary and hypothalamus. Cell. Mol. Neurobiol. 1995, 15:289-296.
232. Raison C.L., Demetrashvili M., Capuron L., Miller A.H. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. C.N.S. Drugs. 2005, 19:105-123.
233. Ramachandra R.N., Sehon A.H., Berczi I. Neurohormonal host defence in endotoxin shock. Brain Behav. Immun. 1992, 6:157-169.
234. Redei E.E., Ahmadiyeh N., Baum A.E., Sasso D.A., Slone J.L., Solberg L.C., et al. Novel animal models of affective disorders. Semin. Clin. Neuropsychiatry. 2001, 6:43-67.
235. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 2001, 58:445-452.
236. Reyes T.M., Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 2002, 22:5091-5099.
237. Rezvani A.H., Parsian A., Overstreet D.H. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr. Genet. 2002, 12:1-16.
238. Riedel W.J., Klaassen T., Schmitt J.A. Tryptophan, mood, and cognitive function. Brain Behav. Immun. 2002, 16:581-589.
239. Robinson C.M., Shirey K.A., Carlin J.M. Synergistic transcriptional activation of indoleamine dioxygenase by IFNgamma and tumor necrosis factor-alpha. J. Interferon Cytokine Res. 2003, 23:413-421.
240. Rohleder N., Kudielka B.M., Hellhammer D.H., Wolf J.M., Kirschbaum C. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J. Neuroimmunol. 2002, 126:69-77.
241. Romanovsky A.A. Thermoregulatory manifestations of systemic inflammation: lessons from vagotomy. Auton. Neurosci. 2000, 85:39-48.
242. Romeo H.E., Tio D.L., Rahman S.U., Chiappelli F., Taylor A.N. The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity. J. Neuroimmunol. 2001, 115:91-100.
243. Romeo H.E., Tio D.L., Taylor A.N. Effects of glossopharyngeal nerve transection on central and peripheral cytokines and serum corticosterone induced by localized inflammation. J. Neuroimmunol. 2003, 136:104-111.
244. Rossi-George A., LeBlanc F., Kaneta T., Urbach D., Kusnecov A.W. Effects of bacterial superantigens on behavior of mice in the elevated plus maze and light-dark box. Brain Behav. Immun. 2004, 18:46-54.
245. Rossi-George A., Urbach D., Colas D., Goldfarb Y., Kusnecov A.W. Neuronal, endocrine, and anorexic responses to the T-cell superantigen staphylococcal enterotoxin A: dependence on tumor necrosis factor-alpha. J. Neurosci. 2005, 25:5314-5322.
246. Roth J., De Souza G.E. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz. J. Med. Biol. Res. 2001, 34:301-314.
247. Sachot C., Poole S., Luheshi G.N. Circulating leptin mediates lipopolysaccharide-induced anorexia and fever in rats. J. Physiol. 2004, 561:263-272.
248. Santoso D.I., Rogers P., Wallace E.M., Manuelpillai U., Walker D., Subakir S.B. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta. 2002, 23:373-379.
249. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J., et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 1997, 185:171-175.
250. Satta M.A., Jacobs R.A., Kaltsas G.A., Grossman A.B. Endotoxin induces interleukin-1beta and nitric oxide synthase mRNA in rat hypothalamus and pituitary. Neuroendocrinology. 1998, 67:109-116.
251. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005, 29:201-217.
252. Schiltz J.C., Sawchenko P.E. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J. Neurosci. 2002, 22:5606-5618.
253. Schmidt E.D., Aguilera G., Binnekade R., Tilders F.J. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraven nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience. 2003, 116:275-283.
254. Schmidt E.D., Schoffelmeer A.N., De Vries T.J., Wardeh G., Dogterom G., Bol J.G., et al. A single administration of interleukin-1 or amphetamine induces long-lasting increases in evoked noradrenaline release in the hypothalamus and sensitization o corticosterone responses in rats. Eur. J. Neurosci. 2001, 13:1923-1930.
255. Schulz D., Topic B., De Souza Silva M.A., Huston J.P. Extinction-induced immobility in the water maze and its neurochemical concomitants in aged and adult rats: a possible model for depression?. Neurobiol. Learn. Mem. 2004, 82:128-141.
256. Schwartz G.J., Plata-Salaman C.R., Langhans W. Subdiaphragmatic vagal deafferentation fails to block feedingsuppressive effects of LPS and IL-1 beta in rats. Am. J. Physiol. 1997, 273:R1193-R1198.
257. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 2000, 404:661-671.
258. Segall M.A., Crnic L.S. An animal model for the behavioral effects of interferon. Behav. Neurosci. 1990, 104:612-618.
259. Shuto H., Kataoka Y., Horikawa T., Fujihara N., Oishi R. Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res. 1997, 747:348-351.
260. Simmons D.A., Broderick P.A. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005, 29:793-807.
261. Slotkin T.A., Miller D.B., Fumagalli F., McCook E.C., Zhang J., Bissette G., Seidler F.J. Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats. J. Pharmacol. Exp. Ther. 1999, 289:334-345.
262. Smoak K.A., Cidlowski J.A. Mechanisms of glucocorticoid receptor signaling during inflammation. Mech. Aging Dev. 2004, 125:697-706.
263. Sobczak S., Honig A., Nicolson N.A., Riedel W.J. Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched contr. Neuropsychopharmacology. 2002, 27:834-842.
264. Song C., Leonard B.E., Horrobin D.F. Dietary ethyleicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress. 2004, 7:43-54.
265. Sonti G., Ilyin S.E., Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Peptides. 1996, 17:517-520.
266. Spurlock M.E. Regulation of metabolism and growth during immune challenge: an overview of cytokine function. J. Anim. Sci. 1997, 75:1773-1783.
267. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 2003, 37:357-373.
268. Strike P.C., Wardle J., Steptoe A. Mild acute inflammatory stimulation induces transient negative mood. J. Psychosom. Res. 2004, 57:189-194.
269. Swiergiel A.H., Dunn A.J. Cyclooxygenase 1 is not essential for hypophagic responses to interleukin-1 and endotoxin in mice. Pharmacol. Biochem. Behav. 2001, 69:659-663.
270. Swiergiel A.H., Dunn A.J. Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes. J. Pharmacol. Exp. Ther. 2002, 302:1031-1036.
271. Swiergiel A.H., Smagin G.N., Johnson L.J., Dunn A.J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res. 1997, 776:96-104.
272. Szekely M., Balasko M., Kulchitsky V.A., Simons C.T., Ivanov A.I., Romanovsky A.A. Multiple neural mechanisms of fever. Auton. Neurosci. 2000, 85:78-82.
273. Takao T., Tracey D.E., Mitchell W.M., De Souza E.B. Interleukin-1 receptors in mouse brain: characterization and neuronal localization. Endocrinology. 1990, 127:3070-3078.
274. Tazi A., Dantzer R., Crestani F., Le Moal M. Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity. Brain Res. 1988, 473:369-371.
275. Uehara A., Ishikawa Y., Okumura T., Okamura K., Sekiya C., Takasugi Y., Namiki M. Indomethacin blocks the anorexic action of interleukin-1. Eur. J. Pharmacol. 1989, 170:257-260.
276. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. Anorexia induced by interleukin 1, involvement of corticotropin-releasing factor. Am. J. Physiol. 1989, 257:R613-R617.
277. Vallieres L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinf cytokine interleukin-1beta. J. Neurochem. 1997, 69:1668-1683.
278. van Dam A.M., Bauer J., Tilders F.J., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience. 1995, 65:815-826.
279. van Dam A.M., Brouns M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific sym sickness?. Brain Res. 1992, 588:291-296.
280. van Dam A.M., De Vries H.E., Kuiper J., Zijlstra F.J., De Boer A.G., Tilders F.J., Berkenbosch F. Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction?. FASEB J. 1996, 10:351-356.
281. van Dam A.M., Poole S., Schultzberg M., Zavala F., Tilders F.J. Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Ann. N. Y. Acad. Sci. 1998, 840:128-138.
282. Van der Does A.J. The effects of tryptophan depletion on mood and psychiatric symptoms. J. Affect. Disord. 2001, 64:107-119.
283. Vitkovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Mol. Psychiatry 2000, 5:604-615.
284. Vitkovic L., Maeda S., Sternberg E. Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation. 2001, 9:295-312.
285. Wan W., Wetmore L., Sorensen C.M., Greenberg A.H., Nance D.M. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain. Brain Res. Bull. 1994, 34:7-14.
286. Watanabe S., Kanada S., Takenaka M., Hamazaki T. Dietary n-3 fatty acids selectively attenuate LPS-induced behavioral depression in mice. Physiol. Behav. 2004, 81:605-613.
287. Watkins L.R., Maier S.F. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu. Rev. Psychol. 2000, 51:29-57.
288. Watkins L.R., Maier S.F., Goehler L.E. Cytokine-tobrain communication: a review & analysis of alternative mechanisms. Life Sci. 1995, 57:1011-1026.
289. Widner B., Ledochowski M., Fuchs D. Interferongamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. Curr. Drug Metab. 2000, 1:193-204.
290. Wieczorek M., Swiergiel A.H., Pournajafi-Nazarloo H., Dunn A.J. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice. Physiol. Behav. 2005, 85:500-511.
291. Willner P., Mitchell P.J. The validity of animal models of predisposition to depression. Behav. Pharmacol. 2002, 13:169-188.
292. Wisse B.E., Ogimoto K., Morton G.J., Wilkinson C.W., Frayo R.S., Cummings D.E., Schwartz M.W. Physiological regulation of hypothalamic IL-1beta gene expression by leptin and glucocorticoids: implications for energy homeostasis. Am. J. Physiol. Endocrinol. Metab. 2004, 287:E1107-E1113.
293. Wong M.L., Bongiorno P.B., Rettori V., McCann S.M., Licinio J. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic infla pathophysiological implications. Proc. Natl. Acad. Sci. USA. 1997, 94:227-232.
294. Wong M.L., Rettori V., al-Shekhlee A., Bongiorno P.B., Canteros G., McCann S.M., et al. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 1996, 2:581-584.
295. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav. Immun. 2005, 19:345-350.
296. Wu D., Yang J., Pardridge W.M. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J. Clin. Invest. 1997, 100:1804-1812.
297. Xu B., Dube M.G., Kalra P.S., Farmerie W.G., Kaibara A., Moldawer L.L., et al. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology. 1998, 139:466-473.
298. Yao J., Johnson R.W. Induction of interleukin-1 betaconverting enzyme (ICE) in murine microglia by lipopolysaccharide. Brain Res. Mol. Brain. Res. 1997, 51:170-178.
299. Yirmiya R., Weidenfeld J., Pollak Y., Morag M., Morag A., Avitsur R., et al. Cytokines, "depression due to a general medical condition," and antidepressant drugs. Adv. Exp. Med. Biol. 1999, 461:283-316.
300. Young S.N., Gauthier S. Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS. Adv. Exp. Med. Biol. 1981, 133:221-230.
301. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., Nance D.M. Interleukin-2 and-6 induce behavioral-activating effects in mice. Brain Res. 1998, 811:111-121.
302. Zalcman S., Savina I., Wise R.A. Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res. 1999, 847:276-283.
303. Zalcman S.S. Interleukin-2 potentiates novelty-and GBR 12909-induced exploratory activity. Brain Res. 2001, 899:1-9.
304. Zalcman S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res. 2002, 944:157-164.
305. Zhao L., Brinton R.D. Suppression of proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha in astrocytes by a V1 vasopressin receptor agonist: a cAMP respons element-binding protein-dependent mechanism. J. Neurosci. 2004, 24:2226-2235.
306. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6, relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993, 133:2523-2530.
307. Zuckerman S.H., Shellhaas J., Butler L.D. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids a of the pituitary-adrenal axis. Eur. J. Immunol. 1989, 19:301-305.